Deep venous thrombosis thrombosis of the leg
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Group 1: - At least 18 years of age and willing to provide informed consent - Newly diagnosed second ipsilateral acute DVT with symptom onset within 10 days - Non-compressibility of the common femoral vein and/or popliteal vein on compression ultrasonography in a segment that is clearly different from the first episode - Positive D-dimer test;Group 2: - At least 18 years of age and willing to provide informed consent - Chronic symptoms of postthrombotic syndrome, but no symptoms of acute DVT - Complete or partial non-compressibility of 1 or more proximal deep veins on compression ultrasonography -The last deep vein thrombosis has been longer than 6 months ago - Negative D-dimer test
Exclusion criteria
Exclusion criteria: - Younger than 18 years of age - Patients who received an investigational drug within 30 days of enrolment - Patients who have undergone a study with MRI in the previous 48 hours - Patients with lower limb amputation - Patients with a medical condition, associated illness, or co-morbid circumstances that made it unlikely that the study procedure would be completed - Patients with a MRI contra-indication: - A pacemaker or subcutaneous defibrillator of the heart - Clips in the vascular system of the brains - Metal fragments in the eye - An hearing aid which cann't be removed - A neurostimulator which cann't be removed - An hydrocephalus pump - Denture which are fixed by magnets - A metal intrauterine device - (The possibility of) being pregnant - Claustrophobic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary study parameters are the sensitivity and specificity of MRDTI for diagnosing acute recurrent DVT. The sensitivity of MRDTI is determined by calculating the proportion of scans that are read as "positive for acute recurrent DVT" in group 1 patients and the specificity is determined by calculating the proportion of scans that are read as " negative for acute DVT" in group 2 patients. " | — |
Secondary
| Measure | Time frame |
|---|---|
| Doesn't apply | — |
Countries
Netherlands